As per the agreement, HeartWare will receive an option to fund programs to explore developments in bi-ventricular support and first rights to future developments outside the field of TETS and ventricular assist devices.
The Dualis wireless TETS for implantable devices is designed to facilitate patients to safely and efficiently provide power during normal daily activities.
Dualis said by coupling an external sender coil with an implanted receiver coil, the TETS system is able to transfer electricity through the patient’s skin, thereby eliminating the traditional power and transmitter cable utilized in ventricular assist devices today.
Dualis MedTech CEO and MD Thomas Schmid said at Dualis, their primary focus with this first initiative with HeartWare is to harness their proprietary and established energy transfer system to work with its HVAD and MVAD pumps.
"We are delighted to now have an opportunity to marry our advanced system with the LVAD technology and look forward to a long and productive partnership with HeartWare as we pursue our mission of creating intelligent implants to treat poorly managed medical conditions," Schmid said.
